ABCL

AbCellera Biologics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website abcellera.com
Employees(FY) 630
ISIN CA00288U1066

Performance

-9.8%

-6.97%

-1.48%

-26.65%

-53.24%

YTD

-41.96%

Profile

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Advanced Technical Analysis

Technical Analysis of ABCL 2024-11-20

The stock indicators reflect a predominantly bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 40 suggesting a neutral stance, and a Technical Score of 25 reinforcing the overall bearish outlook. This combination signals caution for potential investors, as the prevailing trend appea...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ABCL

Stock Rank

Recent News & Updates

2024-11-07 10:05
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024(Business Wire)
2024-11-07 07:48
AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates(Simply Wall St.)
2024-11-06 21:05
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024(Businesswire)
2024-11-06 07:10
AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations(Simply Wall St.)
2024-11-05 11:17
Q3 2024 Abcellera Biologics Inc Earnings Call(Thomson Reuters StreetEvents)
2024-11-05 02:11
AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...(GuruFocus.com)
2024-11-04 23:00
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript(Motley Fool)
2024-11-04 17:55
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates(Zacks)
2024-11-04 16:05
AbCellera Reports Q3 2024 Business Results(Business Wire)
2024-11-04 03:05
AbCellera Reports Q3 2024 Business Results(Businesswire)
2024-10-31 21:06
AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of Earnings(Yahoo Finance)
2024-10-22 16:05
AbCellera to Present at Upcoming Investor Conferences in November 2024(Business Wire)
2024-10-21 10:31
3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap(Simply Wall St.)
2024-10-16 08:58
Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts?(Insider Monkey)
2024-10-04 09:00
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024(Business Wire)
2024-10-03 21:00
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024(Businesswire)
2024-09-26 16:05
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024(Business Wire)
2024-09-26 04:05
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024(Businesswire)
2024-09-01 22:26
AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?(Insider Monkey)
2024-09-01 10:26
AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?(Insidermonkey)
2024-08-31 08:13
Carl Hansen Buys Handful Of Shares In AbCellera Biologics(Simply Wall St.)
2024-08-30 06:48
Daily – Vickers Top Buyers & Sellers for 08/30/2024(Argus Research)
2024-08-29 16:05
AbCellera to Present at Upcoming Investor Conferences in September(Business Wire)
2024-08-29 08:41
10 Best Multibagger Penny Stocks of 2025(Insidermonkey)
2024-08-29 05:13
AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024(Insider Monkey)
2024-08-29 04:05
AbCellera to Present at Upcoming Investor Conferences in September(Businesswire)
2024-08-20 06:33
Benchmark Downgrades AbCellera Biologics to Hold From Buy(MT Newswires)
2024-08-11 08:21
Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024(Simply Wall St.)
2024-08-09 06:35
Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts(Simply Wall St.)
2024-08-07 07:43
AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures(Simply Wall St.)

Page 1 of 7

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.